ARTICLE | Clinical News
Dymista azelastine/fluticasone regulatory update
June 10, 2013 7:00 AM UTC
Meda said the Swedish Dental and Pharmaceutical Benefits Agency will reimburse Dymista azelastine/fluticasone to treat seasonal and perennial allergic rhinitis. The product was approved under the EU's...